Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Journal of Neurology
Published in: Journal of Neurology 12/2009

01-12-2009 | Letter to the editors

Infliximab in the treatment of rheumatoid meningoencephalitis

Authors: Felix Luessi, Janina Sollors, Harald Müller, Peter Stoeter, Clemens Sommer, Thomas Vogt, Frank Birklein, Frank Thömke

Published in: Journal of Neurology | Issue 12/2009

Login to get access

Excerpt

Sirs, …
Literature
1.
Arnett FC, Edworthy SM, Bloch DA et al (1988) The American rheumatism association 1987 revised criteria fort he classification of rheumatoid arthritis. Arthritis Rheum 31:315–324CrossRefPubMed
2.
Bathon JM, Moreland LW, DiBartolomeo AG (1989) Inflammatory central nervous system involvement in rheumatoid arthritis. Semin Arthritis Rheum 18:258–266CrossRefPubMed
3.
Kato T, Hoshi K, Sekijima Y et al (2003) Rheumatoid meningitis: an autopsy report and review of the literature. Clin Rheumatol 22:475–480CrossRefPubMed
4.
Chou RC, Henson JW, Tian D et al (2006) Successful treatment of rheumatoid meningitis with cyclophosphamide but not infliximab. Ann Rheum Dis 65:1114–1116CrossRefPubMed
5.
Starosta MA, Brandwein SR (2007) Clinical manifestation and treatment of rheumatoid pachymeningitis. Neurology 68:1079–1080CrossRefPubMed
6.
Sarwar H, McGrath H Jr, Espinoza LR (2005) Successful treatment of long-standing Neuro-Behçet’s disease with infliximab. J Rheumatol 32:181–183PubMed
7.
Sollberger M, Fluri F, Baumann T et al (2004) Successful treatment of steroid-refractory neurosarcoidosis with infliximab. J Neurol 251:760–761CrossRefPubMed
Metadata
Title
Infliximab in the treatment of rheumatoid meningoencephalitis
Authors
Felix Luessi
Janina Sollors
Harald Müller
Peter Stoeter
Clemens Sommer
Thomas Vogt
Frank Birklein
Frank Thömke
Publication date
01-12-2009
Publisher
D. Steinkopff-Verlag
Published in
Journal of Neurology / Issue 12/2009
Print ISSN: 0340-5354
Electronic ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-009-5286-0

Other articles of this Issue 12/2009

Journal of Neurology 12/2009 Go to the issue

Original Communication

Effects of dopaminergic medication on objective tasks of deftness, bradykinesia and force control

Original Communication

C-reactive protein in the very early phase of acute ischemic stroke: association with poor outcome and death

Letter to the editors

Irritability, psychomotor agitation and progressive insomnia induced by bilateral stimulation of the area surrounding the dorsal subthalamic nucleus (zona incerta) in Parkinson’s disease patients

Original Communication

Sleep-related breathing disorders in acute lacunar stroke

Original Communication

Midbrain atrophy in subcortical ischemic vascular dementia

Original Communication

Detecting dysphagia in inclusion body myositis